BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP - Concepedia

Concepedia

Publication | Closed Access

BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP

345

Citations

16

References

2000

Year

Peter Iversen, C. Tyrrell, Amir V. Kaisary, John Anderson, Hendrik Van Poppel, Teuvo L.J. Tammela, M. C. Chamberlain, Kevin Carroll, I. Melezínek

The Journal of Urology

Abstract

Monotherapy with 150 mg. bicalutamide is an attractive alternative to castration in patients with locally advanced prostate cancer for whom immediate hormone therapy is indicated.

References

	Year	Citations

Page 1